[Massive secondary psoriasiform dermatitis secondary to intravesical administration of mitomycin C].
We report on a patient who had been submitted to vesical diverticulectomy. Pathological examination of the surgical specimen revealed G2T1 urothelial carcinoma. Intravesical chemotherapy with mitomycin C was instituted. Following the sixth instillation, the patient developed widespread psoriasiform dermatitis and required admission to hospital. Remission was achieved with drug withdrawal and symptomatic treatment. The literature is reviewed.
Arrizabalaga
M
M
Casanueva
T
T
Benítez
J
J
Escribano
G
G
Gallardo
C
C
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D016685:Mitomycin; D008937:Mitomycins / Q000009:adverse effects* / Q000627:therapeutic use; D011565:Psoriasis / Q000139:chemically induced*
D000970:Antineoplastic Agents; D008937:Mitomycins; D016685:Mitomycin
Dermatitis psoriasiforme masiva secundaria a instilación intravesical de mitomycin C.